Drugs Made In America Acquisition Corp
DMAAU10.460USD
-0.120-1.13%
시장 운영 시간 （ET）시세는 15분 지연됩니다
0.00시가총액
--P/E TTM
자세한 내용은 Drugs Made In America Acquisition Corp 회사
Drugs Made In America Acquisition Corp. is a blank check company. The Company is incorporated as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus its search for business combination targets in the pharmaceutical industry.
회사 정보
종목 코드 DMAAU
회사 이름Drugs Made In America Acquisition Corp
상장일Jan 28, 2025
CEOMs. Lynn Stockwell
직원 수- -
유형Unit
회계 연도 종료- -
주소1 East Broward Boulevard
도시FT LAUDERDALE
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호33301
전화19548703099
웹사이트
종목 코드 DMAAU
상장일Jan 28, 2025
CEOMs. Lynn Stockwell
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, May 17
마지막 업데이트: Sat, May 17
주주
주주 유형
주주
주주
비율
Drugs Made In America Acquisition LLC
17.88%
Heights Capital Management, Inc.
2.77%
Boothbay Fund Management, LLC
2.58%
Westchester Capital Management, LLC
2.13%
RiverNorth Capital Management LLC
1.79%
Other
72.84%
주주
주주
비율
Drugs Made In America Acquisition LLC
17.88%
Heights Capital Management, Inc.
2.77%
Boothbay Fund Management, LLC
2.58%
Westchester Capital Management, LLC
2.13%
RiverNorth Capital Management LLC
1.79%
Other
72.84%
주주 유형
주주
비율
Corporation
17.88%
Investment Advisor/Hedge Fund
7.68%
Hedge Fund
3.54%
Investment Advisor
2.85%
Research Firm
0.03%
Other
68.02%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
20
7.49M
31.98%
+7.31M
2025Q1
20
7.60M
32.43%
+7.41M
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Heights Capital Management, Inc.
650.00K
2.77%
+650.00K
--
Mar 31, 2025
Boothbay Fund Management, LLC
603.75K
2.58%
+603.75K
--
Mar 31, 2025
Westchester Capital Management, LLC
500.00K
2.13%
+500.00K
--
Mar 31, 2025
RiverNorth Capital Management LLC
420.50K
1.79%
+418.00K
+16719.92%
Mar 31, 2025
Context Capital Management LLC
250.00K
1.07%
+250.00K
--
Mar 31, 2025
Schonfeld Strategic Advisors LLC
234.83K
1%
+234.83K
--
Mar 31, 2025
Bulldog Investors, LLP
130.26K
0.56%
+130.26K
--
Mar 31, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
+130.00K
--
Mar 31, 2025
Verition Fund Management LLC
100.00K
0.43%
+100.00K
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
SPAC and New Issue ETF
2.39%
RiverNorth Enhanced Pre-Merger SPAC ETF
0.51%
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
비율2.39%
RiverNorth Enhanced Pre-Merger SPAC ETF
비율0.51%
CrossingBridge Pre-Merger SPAC ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
